Patients suffering from chronic kidney disease show decreased free serum fetuin-A and increased serum fetuin-A mineral complexes [17], which can be quantified by a nanoparticle-based serum test measuring overall calcification inhibition [56]. The gene discussed is AHSG; the disease is chronic kidney disease.